About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Lancet Respiratory Medicine,the
›
Top Articles
Lancet Respiratory Medicine,the
35.1
(top 1%)
Impact Factor
38.3
(top 1%)
extended IF
151
(top 2%)
H-Index
2.5K
authors
2.1K
papers
98.1K
citations
5.8K
citing journals
70.9K
citing authors
Most Cited Articles of Lancet Respiratory Medicine,the
Title
Year
Citations
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
2020
5.6K
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
2020
5K
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
2020
1.7K
Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study
2015
1.2K
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
2017
1.1K
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
2020
812
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis
2019
730
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
2020
727
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
2015
715
COVID-19 cytokine storm: the interplay between inflammation and coagulation
2020
685
Rational use of face masks in the COVID-19 pandemic
2020
652
Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials
2014
596
E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis
2016
566
Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit
2014
566
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
2016
487
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials
2015
474
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
2020
469
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
2020
461
Respiratory risks from household air pollution in low and middle income countries
2014
459
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
2015
457
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
2018
452
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
2014
405
Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial
2014
400
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
2019
398
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
2020
395
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.